Researchers have developed a new technology that can shape the spectrum of light emitted from a laser frequency comb across ...

Former special counsel Jack Smith excoriated the Justice Department over its indictment of former FBI Director James Comey, saying it "reeks of a lack of process," and he also weighed in on other ...

Construction began on Phase II of the Modoc Multi Use Path on Monday, Oct. 6. The $6.5 million project will complete an eight-mile-long Class I (multi-use) path network from Isla Vista to Arroyo Burro ...

Clinical-stage immuno-oncology company GT Biopharma Inc. (NASDAQ:GTBP) announced on Wednesday that enrollment in the dose escalation cohorts of the Phase 1 trial of GTB-3650 for relapsed or refractory ...

President Trump on Wednesday said he planned to use money brought in from tariffs on imports to provide aid to soybean farmers who have been hurt by a trade dispute with China. “The Soybean Farmers of ...

President Donald Trump on Tuesday signaled that he would make greater use of the U.S. military to quell disturbances in Democratic-run cities across the United States, warning of a “war from within” ...

U.S. President Donald Trump speaks to senior military leaders at Marine Corps Base Quantico on September 30, 2025 in Quantico, Virginia. In an unprecedented gathering, almost 800 generals, admirals ...

As if you didn’t have enough to worry about when it comes to surveillance, researchers have discovered a new way to identify and track people using Wi-Fi signals—and I’m not talking about anything ...

London-based artificial intelligence startup Signal Media Ltd., better known as Signal AI, today announced it has raised $165 million in new growth-equity funding led by Battery Ventures. Following ...

NEW YORK — Audioboom, a podcast company with a global print, is welcoming a VP of International from British podcast network Adelicious. He steps into an expanded role that “will be pivotal to ...

Genfit has stopped development of VS-01 in acute-on-chronic liver failure (ACLF) after a patient suffered a serious adverse event in a phase 2 trial. The French drugmaker acquired VS-01 when it bought ...